Liminal Biosciences (NASDAQ: LMNL)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Liminal Biosciences (NASDAQ: LMNL) through any online brokerage.
There are no as such competitors for Liminal Biosciences.
The latest price target for Liminal Biosciences (NASDAQ: LMNL) was reported by HC Wainwright & Co. on Thursday, June 24, 2021. The analyst firm set a price target for 0.00 expecting LMNL to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
The stock price for Liminal Biosciences (NASDAQ: LMNL) is $0.49 last updated August 9, 2022, 7:24 PM UTC.
There are no upcoming dividends for Liminal Biosciences.
Liminal Biosciences’s Q2 earnings are confirmed for Tuesday, August 23, 2022.
There is no upcoming split for Liminal Biosciences.
Liminal Biosciences is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.